Putting the customer at the core of your product development ensures relevance and resonance.
The FTC Wrongly Blames PBMs for High Drug Prices
Putting the customer at the core of your product development ensures relevance and resonance.
New Study Shows PBMs Lower Drug Prices
A new report challenges assertions made during the committee’s recent hearing on the role of pharmacy benefit managers.
Antitrust Regulators Play Monopoly: Rolling the Dice on Artificial Intelligence
Antitrust investigations of AI companies will likely stifle innovation and jeopardize US global competitiveness.
Broadband Rollout Requires Municipal Permitting Reform
Municipal leaders can expand broadband connectivity by lifting restraints on cell towers, fiber, and utility pole attachments.
DOJ Sets its Antitrust Eyes on Live Nation – Ticketmaster
DOJ’s suit will likely fail to promote competition or bring down prices for consumers in the long run.
USPS Plan Cannot Be Delivered As PMG DeJoy Obstinately Claims
Despite growing evidence of problems, PMG DeJoy doubles down on his Delivering for America plan to supposedly save USPS.
The FTC Wrongly Blames PBMs for High Drug Prices
The FTC fails to acknowledge the benefits of pharmacy benefit managers and wrong blames them for high drug prices.
SCOTUS Delivers a Blow to the Regulatory State
Chevron deference is overturned by the Supreme Court in its ruling in favor of Loper Bright Enterprises.
GAO Annual Report Provides Opportunities to Cut Wasteful Spending
Government Accountability Office suggests cost-cutting measures for student loans, federal office space, and other expenditures